Adze Biotechnology Doses First Patient in Australia in Phase 1 Trial of ADZE1.C for Advanced Melanoma
Dosing took place at The Queen Elizabeth Hospital (TQEH) in Adelaide, South Australia, under the direction of principal investigator Dr. Rachel Roberts-Thomson. CORAL GABLES, FL, UNITED STATES, June 15, 2026 /EINPresswire.com/ -- Adze …